Business Description

Description
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 3.52
Equity-to-Asset 0.13
Debt-to-Equity 1.43
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -76.66
Distress
Grey
Safe
Beneish M-Score -2.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 12.45
9-Day RSI 15.13
14-Day RSI 20.54
6-1 Month Momentum % -51.29
12-1 Month Momentum % -94.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.98
Quick Ratio 0.98
Cash Ratio 0.87
Days Sales Outstanding 313.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -58.6
Shareholder Yield % -1281.91

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -847.42
Net Margin % -569.65
FCF Margin % -849.92
ROA % -107
ROIC % -635.54
ROC (Joel Greenblatt) % -3919.4
ROCE % -308.18

Financials (Next Earnings Date:2024-05-10 Est.)

ARAV's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARAV

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aravive Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.995
EPS (TTM) ($) -0.96
Beta 0
Volatility % 117.57
14-Day RSI 20.54
14-Day ATR ($) 0.006293
20-Day SMA ($) 0.06148
12-1 Month Momentum % -94.21
52-Week Range ($) 0.04 - 2.46
Shares Outstanding (Mil) 73.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aravive Inc Filings

Filing Date Document Date Form
No Filing Data

Aravive Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aravive Inc Frequently Asked Questions

What is Aravive Inc(ARAV)'s stock price today?
The current price of ARAV is $0.04. The 52 week high of ARAV is $2.46 and 52 week low is $0.04.
When is next earnings date of Aravive Inc(ARAV)?
The next earnings date of Aravive Inc(ARAV) is 2024-05-10 Est..
Does Aravive Inc(ARAV) pay dividends? If so, how much?
Aravive Inc(ARAV) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1